It might be time to start shopping “down market”, says Jennifer Hughes in the Financial Times. The Russell 2000 index of US small and mid-sized firms has been having a miserable year, gaining less than 1% even as the large-cap S&P 500 soars 17.5%.
Over six months, “small caps have only underperformed their bigger cousins this badly at two other points since the 2000 dotcom boom”. While mega caps rocket due to artificial intelligence fever – Nvidia alone is now “worth roughly as much as the entire Russell 2000” – struggling small caps suggest that the wider American economy is lethargic.
US small caps and mid caps have generally under-performed US large caps over the past 10 years, says J.P.Morgan’s Sitara Sundar. They are thus trading “at a near record valuation discount” to their large-cap peers. US small and mid-caps are at “the leading edge of innovation”, whether in software or advances in industrial automation. But small and mid caps vary in quality.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
For every exciting small cap, there are ones that “carry high levels of debt or do not generate earnings”, so “active stock picking” is key. Some investors buy small companies in pursuit of the “small-cap premium”, says Ben Carlson on his A Wealth of Common Sense blog. Between 1926 and 2021, US small-cap stocks outperformed large-cap stocks by more than 10%.
“Others dispute whether the premium is real, but whatever the truth, small caps are invaluable as a portfolio diversifier”. That’s especially true in periods like today where large-cap valuations are vulnerable to a reversal.
“The last time small caps lagged in a big way was the late 1990s when the dotcom bubble went into hyperdrive”. When the bubble burst, it was the undervalued small caps that “outperformed in a big way during the next cycle”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
HMRC confirms crypto ETN ISA statusWith crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pension investors targeted by fine wine scams – the tactics to watch forWine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great againConservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging marketsOpinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growthPinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summerThe US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with folliesThe best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuationAEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefullyShares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
